Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study

OBJECTIVE: Several molecules are involved in the pathogenesis of a new bone formation in ankylosing spondylitis (AS). The aim of this study was to evaluate the serum levels of sclerostin in patients with AS as a possible biomarker and to investigate any correlations with radiographic damage, disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrotta, Fabio Massimo, Ceccarelli, Fulvia, Barbati, Cristiana, Colasanti, Tania, De Socio, Antonia, Scriffignano, Silvia, Alessandri, Cristiano, Lubrano, Ennio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954944/
https://www.ncbi.nlm.nih.gov/pubmed/29854850
http://dx.doi.org/10.1155/2018/9101964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954944/
https://www.ncbi.nlm.nih.gov/pubmed/29854850
http://dx.doi.org/10.1155/2018/9101964

Ejemplares similares